Medicago to be acquired by Mitsubishi Tanabe Pharma

Stockhouse Editorial
1 Comment| July 12, 2013


Medicago (TSX: T.MDG, Stock Forum) Thursday announced that it has entered into a definitive arrangement agreement whereby Mitsubishi Tanabe Pharma Corporation will acquire all of the issued and outstanding common shares of Medicago, other than the shares currently held by an affiliate of Philip Morris International, for $1.16 per share in cash

Upon completion of the transaction, Medicago will be jointly owned by Mitsubishi Tanabe Pharma (60%) and Philip Morris (40%).

Medicago is a biopharmaceutical company focused on developing vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs). 


Rate this article
5 stars
v
Usefulness

Clarity

Credibility

Comments

kungfu010
Could there be a second bid from SVA in China?
2.5 stars
July 12, 2013
Rate this comment
0 stars
v
Usefulness

Clarity

Credibility

Leave a Message

You must be logged in to access this feature.